immunoSCAPE’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

immunoSCAPE is a biotechnology firm that develops and commercializes therapies to take advantage of the adaptive immune system to treat cancer. Read more

Choon-Peng Ng's photo - Co-Founder & CEO of immunoSCAPE

Co-Founder & CEO

Choon-Peng Ng

CEO Approval Rating

90/100

Founded:

2016

Status:

Est. Annual Revenue
Est. Employees

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Adaptive Biotechnologies is seen as one of immunoSCAPE's top competitors. Adaptive Biotechnologies was founded in Seattle, Washington} in 2009. Adaptive Biotechnologies is in the Biotechnology industry. Compared to immunoSCAPE, Adaptive Biotechnologies generates $90.1M more revenue.

IFM is immunoSCAPE's #2 competitor. IFM was founded in 2015, and its headquarters is in Boston, Massachusetts. IFM competes in the Pharmaceuticals industry. IFM has 11 more employees than immunoSCAPE.

ImCheck is immunoSCAPE's #3 rival. ImCheck is headquartered in Marseille, Provence-Alpes-Côte-d'Azur, and was founded in 2015. Like immunoSCAPE, ImCheck also competes in the Biotechnology industry. ImCheck generates ∞% the revenue of immunoSCAPE.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is $ < 1M a good estimate for immunoSCAPE's revenue?

Acquisitions

No recent acquisitions found related to immunoSCAPE

immunoSCAPE Funding History

$11M

Since immunoSCAPE was founded in 2016, it has participated in 1 round of funding. In total immunoSCAPE has raised $11.0M. immunoSCAPE's funding round was on Aug 2020 for a total of $11.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Venture Round
Aug 2020
$11M

Anzu Partners

Total Funding: $11M

Since immunoSCAPE was founded in 2016, it has participated in 1 round of funding. In total immunoSCAPE has raised $11.0M. immunoSCAPE's funding round was on Aug 2020 for a total of $11.0M

Investments

No recent investments found related to immunoSCAPE

immunoSCAPE News

immunoSCAPE Videos

Headquarters

1 Scotts Road 24-10

Singapore, Central Singapore228208

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

immunoSCAPE is a biotechnology firm that develops and commercializes therapies to take advantage of the adaptive immune system to treat cancer. immunoSCAPE was founded in 2016. immunoSCAPE's headquarters is located in Singapore, Central Singapore, SG ...

CEO

immunoSCAPE's Co-Founder & CEO, Choon-Peng Ng, currently has an approval rating of 90%. immunoSCAPE's primary competitors are Adaptive Biotechnologies, IFM & ImCheck.

Website

immunoscape.com

Frequently Asked Questions about immunoSCAPE

  1. When was immunoSCAPE founded?

    immunoSCAPE was founded in 2016
  2. Who is immunoSCAPE's CEO?

    immunoSCAPE's CEO is Choon-Peng Ng
  3. How much revenue does immunoSCAPE generate?

    immunoSCAPE generates $ < 1M in revenue
  4. How much funding does immunoSCAPE have?

    immunoSCAPE has historically raised $11M in funding
  1. Where is immunoSCAPE's headquarters?

    immunoSCAPE's headquarters is in Singapore Central Singapore, SG
  2. How many employees does immunoSCAPE have?

    immunoSCAPE has 24 employees
  3. What sector does immunoSCAPE operate in?

    immunoSCAPE is in Biotechnology
  4. Who are immunoSCAPE's competitors?

    immunoSCAPE's top competitors are Adaptive Biotechnologies, IFM, ImCheck